Prescription drug · NDA
Wegovy (Semaglutide) NDC 0169-4409
Semaglutide 9 mg/1 · Tablet · Oral · Novo Nordisk Pharmaceutical Industries, LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0169-4409-31 | 00169440931 | 30 TABLET in 1 BOTTLE, PLASTIC (0169-4409-31)Marketed from Jan 6, 2026 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Wegovy
- Generic name (nonproprietary)
- semaglutide
- Active ingredients
- Semaglutide — 9 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Novo Nordisk Pharmaceutical Industries, LPNDC labeler code 0169
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 218316
- Marketing start
- Listing expires
- Other FDA classes
- Glucagon-Like Peptide 1 (Chemical structure)Glucagon-like Peptide-1 (GLP-1) Agonists (Mechanism)
- Identifiers
- Product ID 0169-4409_f7b108b9-f276-4e32-84e7-e828ba145da5SPL ID f7b108b9-f276-4e32-84e7-e828ba145da5
- Pharmacologic class
- GLP-1 Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400169440931followed by a unit qualifier and the quantityPackage 00169-4409-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0169-4409
- What is NDC 0169-4409?
- 0169-4409 is the product NDC for Wegovy (semaglutide), Semaglutide 9 mg/1 tablet, listed with the FDA by Novo Nordisk Pharmaceutical Industries, LP. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Wegovy (Semaglutide).
- What is the active ingredient?
- Semaglutide.
- Who is the labeler?
- Novo Nordisk Pharmaceutical Industries, LP, NDC labeler code 0169. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Wegovy?
- 11 other product NDCs are listed under this name. See all Wegovy NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Wegovy products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Wegovysemaglutide | Semaglutide 4 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4404 | 00169-4404-31 |
| Wegovysemaglutide | Semaglutide 1.5 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4415 | 00169-4415-3100169-4415-92 |
| Wegovysemaglutide | Semaglutide 25 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4425 | 00169-4425-31 |
| Wegovysemaglutide | Semaglutide 1 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4501 | 00169-4501-14 |
| Wegovysemaglutide | Semaglutide .5 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4505 | 00169-4505-14 |
| Wegovysemaglutide | Semaglutide .25 mg/.5mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-5824 | 50090-5824-00 |
| Wegovysemaglutide | Semaglutide 1.7 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4517 | 00169-4517-14 |
| Wegovysemaglutide | Semaglutide 2.4 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4524 | 00169-4524-14 |
| Wegovysemaglutide | Semaglutide .25 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4525 | 00169-4525-1400169-4525-94 |
| Wegovysemaglutide | Semaglutide 7.2 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4572 | 00169-4572-14 |
Other NDCs under NDA 218316
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Wegovysemaglutide | Semaglutide 1.5 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4415 |
| Wegovysemaglutide | Semaglutide 25 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4425 |
| Wegovysemaglutide | Semaglutide 4 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4404 |